Page last updated: 2024-10-30

leflunomide and Rhabdomyolysis

leflunomide has been researched along with Rhabdomyolysis in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamski, H1
Lopez, L1
Polard, E1
Chevrant-Breton, J1
Dupuy, A1
Rivarola de Gutierrez, E1
Abaca, H1

Other Studies

2 other studies available for leflunomide and Rhabdomyolysis

ArticleYear
Photodistributed eruption with rhabdomyolisis due to leflunomide.
    Photodermatology, photoimmunology & photomedicine, 2011, Volume: 27, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Le

2011
Photodistributed lichenoid drug eruption with rhabdomyolysis occurring during leflunomide therapy.
    Dermatology (Basel, Switzerland), 2004, Volume: 208, Issue:3

    Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Eruptions; Fema

2004